Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Chem Soc ; 143(33): 13034-13043, 2021 08 25.
Artigo em Inglês | MEDLINE | ID: mdl-34378919

RESUMO

Upon photoinitiated electron transfer, charge recombination limits the quantum yield of photoredox reactions for which the rates for the forward reaction and back electron transfer are competitive. Taking inspiration from a proton-coupled electron transfer (PCET) process in Photosystem II, a benzimidazole-phenol (BIP) has been covalently attached to the 2,2'-bipyridyl ligand of [Ir(dF(CF3)ppy)2(bpy)][PF6] (dF(CF3)ppy = 2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine; bpy = 2,2'-bipyridyl). Excitation of the [Ir(dF(CF3)ppy)2(BIP-bpy)][PF6] photocatalyst results in intramolecular PCET to form a charge-separated state with oxidized BIP. Subsequent reduction of methyl viologen dication (MV2+), a substrate surrogate, by the reducing moiety of the charge separated species demonstrates that the inclusion of BIP significantly slows the charge recombination rate. The effect of ∼24-fold slower charge recombination in a photocatalytic phthalimide ester reduction resulted in a greater than 2-fold increase in reaction quantum efficiency.

2.
3.
Health Care Manag (Frederick) ; 38(4): 311-321, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31663869

RESUMO

The 340B Drug Pricing Program, created by Congress in 1992 through the Veterans Health Care Act, has provided discounted drug prices to hospitals and other health care organizations serving a wide population of low-income patients. Some 340B programs use contract pharmacies, an arrangement whereby the hospital or health care organization signs a contract directly with a pharmacy to provide covered pharmacy services at discounted prices. The federal 340B Drug Pricing Program has provided access to reduced price prescription drugs to more than 35 000 individual health care facilities and sites certified by the US Department of Health and Human Services, and clinics have served more than 10 million people in all 50 states, plus commonwealths and US territories. The 340B program has increased profits for hospitals through contract pharmacies because they have still received the same reimbursement but acquired drugs at a lower rate.


Assuntos
Custos e Análise de Custo , Custos de Medicamentos/legislação & jurisprudência , Hospitais/estatística & dados numéricos , Farmácias/economia , Farmácias/organização & administração , Medicamentos sob Prescrição , Humanos , Populações Vulneráveis
4.
Chem Commun (Camb) ; 55(70): 10428-10431, 2019 Aug 27.
Artigo em Inglês | MEDLINE | ID: mdl-31408061

RESUMO

Two new Rh2(ii,ii) dyes were synthesized and anchored to TiO2 for charge injection upon irradiation. The 1ML-LCT (metal/ligand-to-ligand charge transfer) excited state is populated upon excitation, which decays to the corresponding 3ML-LCT state. Ultrafast electron injection into TiO2 from the Rh2(ii,ii) dyes was achieved with low energy, red light excitation.


Assuntos
Luz , Fármacos Fotossensibilizantes/administração & dosagem , Ródio/administração & dosagem , Titânio/administração & dosagem , Elétrons
5.
Chem Commun (Camb) ; 54(60): 8332-8334, 2018 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-29989635

RESUMO

Photocatalytic proton reduction to generate H2 was achieved with the photosensitizers Rh2(DTolF)2(npCOO)2 (DTolF = p-ditolylformamidinate; npCOO- = 2-carboxylate-1,8-naphthyridine; 1) and [Rh2(DTolF)2(qnnp)2][BF4]2 (qnnp = 2-(quinolin-2-yl)-1,8-naphthyridine; 2) using a relay system containing the sacrificial donor BNAH (1-benzyl-1,4-dihydronicotinamide), electron acceptor MV2+ (methylviologen), and Pt nanoparticles as the catalyst with 655 nm irradiation. Comparison of the H2 evolution under similar experimental conditions show comparable activity of the Rh2(ii,ii) complexes (λirr = 655 nm) to that of the prototypical [Ru(bpy)3]2+ (bpy = 2,2'-bipyridine; 3) with λirr = 447 nm. This work demonstrates the ability of the new panchromatic Rh2(ii,ii) complexes to achieve photocatalysis with red light.

6.
J Am Chem Soc ; 140(15): 5161-5170, 2018 04 18.
Artigo em Inglês | MEDLINE | ID: mdl-29617115

RESUMO

A series of dirhodium(II,II) paddlewheeel complexes of the type cis-[Rh2(µ-DTolF)2(µ-L)2][BF4]2, where DTolF = N,N'-di( p-tolyl)formamidinate and L = 1,8-naphthyridine (np), 2-(pyridin-2-yl)-1,8-naphthyridine (pynp), 2-(quinolin-2-yl)-1,8-naphthyridine (qnnp), and 2-(1,8-naphthyridin-2-yl)quinoxaline (qxnp), were synthesized and characterized. These molecules feature new tridentate ligands that concomitantly bridge the dirhodium core and cap the axial positions. The complexes absorb light strongly throughout the ultraviolet/visible range and into the near-infrared region and exhibit relatively long-lived triplet excited-state lifetimes. Both the singlet and triplet excited states exhibit metal/ligand-to-ligand charge transfer (ML-LCT) in nature as determined by transient absorption spectroscopy and spectroelectrochemistry measurements. When irradiated with low-energy light, these black dyes are capable of undergoing reversible bimolecular electron transfer both to the electron acceptor methyl viologen and from the electron donor p-phenylenediamine. Photoinduced charge transfer in the latter was inaccessible with previous Rh2(II,II) complexes. These results underscore the fact that the excited state of this class of molecules can be readily tuned for electron-transfer reactions upon simple synthetic modification and highlight their potential as excellent candidates for p- and n-type semiconductor applications and for improved harvesting of low-energy light to drive useful photochemical reactions.

7.
J Am Chem Soc ; 139(41): 14724-14732, 2017 10 18.
Artigo em Inglês | MEDLINE | ID: mdl-28976191

RESUMO

The new heteroleptic paddlewheel complexes cis-[Rh2(µ-form)2(µ-np)2][BF4]2, where form = p-ditolylformamidinate (DTolF) or p-difluorobenzylformamidinate (F-form) and np = 1,8-napthyridyine, and cis-Rh2(µ-form)2(µ-npCOO)2 (npCOO- = 1,8-naphthyridine-2-carboxylate), were synthesized and characterized. The complexes absorb strongly throughout the ultraviolet (λmax = 300 nm, ε = 20 300 M-1 cm-1) and visible regions (λmax = 640 nm ε = 3500 M-1 cm-1), making them potentially useful new dyes with panchromatic light absorption for solar energy conversion applications. Ultrafast and nanosecond transient absorption and time-resolved infrared spectroscopies were used to characterize the identity and dynamics of the excited states, where singlet and triplet Rh2/form-to-naphthyridine, metal/ligand-to-ligand charge-transfer (ML-LCT) excited states were observed in all four complexes. The npCOO- complexes exhibit red-shifted absorption profiles extending into the near-IR and undergo photoinitiated electron transfer to generate reduced methyl viologen, a species that persists in the presence of a sacrificial donor. The energy of the triplet excited state of each complex was estimated from energy-transfer quenching experiments using a series of organic triplet donors (E(3ππ*) from 1.83 to 0.78 eV). The singlet reduction (+0.6 V vs Ag/AgCl) potentials, and singlet and triplet oxidation potentials (-1.1 and -0.5 V vs Ag/AgCl, respectively) were determined. Based on the excited-state lifetimes and redox properties, these complexes represent a new class of light absorbers with potential application as dyes for charge injection into semiconductor solar cells and in sensitizer-catalyst assemblies for photocatalysis that operate with irradiation from the ultraviolet to ∼800 nm.

8.
Inorg Chem ; 49(10): 4433-9, 2010 May 17.
Artigo em Inglês | MEDLINE | ID: mdl-20397713

RESUMO

A series of five new alpha-hydroxy acid-containing chelates inspired by photoactive marine siderophores, along with their Fe(III) complexes, have been synthesized and characterized. These chelates, designated X-Sal-AHA, each contributes a bidentate salicylidene moiety (X-Sal, X = 5-NO(2), 3,5-diCl, H, 3,5-di-tert-butyl, or 3-OCH(3) on the phenolate ring) and a bidentate alpha-hydroxy acid moiety (AHA). The X-ray crystal structure of Na[Fe(3)(3,5-diCl-Sal-AHA)(3)(mu(3)-OCH(3))] shows an Fe(III) trimer with the triply deprotonated, trianionic ligands each spanning two Fe(III)'s that are bridged by the hydroxyl group of the ligand. Additionally, a mu(3)-methoxy anion caps the Fe(III)(3) face. Electrospray ionization mass spectra demonstrate that this structure is representative of the Fe(III) complexes of all five derivatives in methanol solution, with the exception of the X = 3,5-di-t-Bu derivative having a mu(3)-OH bridge rather than a methoxy bridge. Stability constants determined from reduction potentials range from 10(34) for the 5-NO(2) derivative to >10(40) for the 3,5-di-tBu derivative. All five complexes are photoactive when irradiated by sunlight, with the relative rate of photolysis as monitored by Fe(II) transfer correlating with the Hammett sigma(+) parameter for the phenolate ring substituents.


Assuntos
Hidroxiácidos/química , Quelantes de Ferro/química , Ferro/química , Luz , Absorção , Dicroísmo Circular , Elétrons , Quelantes de Ferro/síntese química , Compostos Organometálicos/síntese química , Compostos Organometálicos/química , Espectrofotometria Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA